ID
41567
Descrição
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Pharmacogenetic Research Consent, Saliva Sample Collection) is to be filled out during the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Palavras-chave
Versões (1)
- 11/11/2020 11/11/2020 -
Titular dos direitos
GlaxoSmithKline
Transferido a
11 de novembro de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
Descrição
Pharmacogenetic research consent
Descrição
Informed consent for pharmacogenetic research
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Descrição
Date informed consent for pharmacogenetics obtained
Tipo de dados
date
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C0011008
Descrição
Saliva collection for pharmacogenetic research
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
Descrição
Date Saliva Sample for pharmacogenetic research was collected
Tipo de dados
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0455046
- UMLS CUI [1,3]
- C0011008
Descrição
Reason for not obtaining informed consent for pharmacogenetic research
Tipo de dados
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C2347500
- UMLS CUI [1,4]
- C1882120
Descrição
Other reason for not obtaining informed consent for pharmacogenetic research
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
- UMLS CUI [1,3]
- C1882120
- UMLS CUI [1,4]
- C0205394
- UMLS CUI [1,5]
- C0566251
Descrição
[hidden] This item will be calculated by InForm
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2347029
Similar models
Pharmacogenetic Research Consent, Saliva Sample Collection
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C2347500 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0455046 (UMLS CUI [1,2])
C0455046 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C2347500 (UMLS CUI [1,3])
C1882120 (UMLS CUI [1,4])
C2347500 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,5])